Replies to post #197648 on Anavex Life Sciences Corp (AVXL)

[TempePhil]

I think the AD approval chances are good. With AD we have some (arguable) efficacy seen. The theory and science research also supports.

I am less confident about Rett and PD trial approvals. We have no efficacy, except for mouse studies. Mouse studies only reflect 10% to 20% success with humans. On the other side, the theory and science still supports. Unfortunately these two trials are up first.
Hopefully I am being to conservative.

I appreciate the estimates given so far! Thanks for answering some hard questions guys! It seems that, in the last few days, the MB has been refreshingly realistic and analytical, without the wild optimism/negativism.